Princess Maxima Center For Pediatric Oncology

This study tests a drug called blinatumomab in infants under 1 year old who have a specific, hard-to-treat type of leukemia. The goal is to improve how long these babies stay cancer-free. About 160 infants will take part, and researchers will track their health over time.

This study tests a combination of drugs (dasatinib, venetoclax, dexamethasone, cyclophosphamide, and cytarabine) in children and young adults up to age 21 whose leukemia or lymphoma has returned or not responded to standard treatment. The goal is to find the safest dose and see h…

This study tests a special fluorescent dye (anti-GD2-800CW) that makes neuroblastoma tumors glow during surgery. About 22 children aged 1 to 18 will receive the dye before their standard tumor removal surgery. The goal is to find a safe and effective dose so surgeons can better s…